- Home
- DSGX vs QGEN Comparison
DSGX vs QGEN Comparison
Compare DSGX & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGX
- QGEN
- Stock Information
- Founded
- DSGX 1981
- QGEN 1986
- Country
- DSGX Canada
- QGEN Netherlands
- Employees
- DSGX N/A
- QGEN N/A
- Industry
- DSGX Computer Software: Prepackaged Software
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DSGX Technology
- QGEN Health Care
- Exchange
- DSGX Nasdaq
- QGEN Nasdaq
- Market Cap
- DSGX 8.4B
- QGEN 9.9B
- IPO Year
- DSGX 1999
- QGEN 1996
- Fundamental
- Price
- DSGX $95.46
- QGEN $38.18
- Analyst Decision
- DSGX Buy
- QGEN Buy
- Analyst Count
- DSGX 12
- QGEN 8
- Target Price
- DSGX $117.42
- QGEN $49.79
- AVG Volume (30 Days)
- DSGX 346.1K
- QGEN 1.1M
- Earning Date
- DSGX 03-05-2025
- QGEN 04-28-2025
- Dividend Yield
- DSGX N/A
- QGEN 3.27%
- EPS Growth
- DSGX 22.39
- QGEN N/A
- EPS
- DSGX 1.64
- QGEN 0.38
- Revenue
- DSGX $651,000,000.00
- QGEN $1,978,214,000.00
- Revenue This Year
- DSGX $13.20
- QGEN $5.15
- Revenue Next Year
- DSGX $12.03
- QGEN $6.49
- P/E Ratio
- DSGX $61.38
- QGEN $105.15
- Revenue Growth
- DSGX 13.63
- QGEN 0.66
- 52 Week Low
- DSGX $87.20
- QGEN $37.63
- 52 Week High
- DSGX $124.31
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- DSGX 37.79
- QGEN 43.07
- Support Level
- DSGX $98.14
- QGEN $39.32
- Resistance Level
- DSGX $104.24
- QGEN $41.44
- Average True Range (ATR)
- DSGX 2.31
- QGEN 0.63
- MACD
- DSGX 0.30
- QGEN 0.09
- Stochastic Oscillator
- DSGX 5.02
- QGEN 0.21
About DSGX Descartes Systems Group Inc. (The)
Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).